Shanghai InnoStar Bio-tech Co Ltd (InnoStar), a subsidiary of China Pharmaceutical Industry Research Institute Co Ltd under China National Pharmaceutical Group Co Ltd (Sinopharm), adheres to the core values of “science orientated, quality first, integrity & dedication, and win-win cooperation”. 

As a leading contract research organization, the company specializes in non-clinical research in the field of biomedicine and is dedicated to offering global pharmaceutical companies and research institutions all-rounded, one-stop services for new drug development that align with both domestic and international declaration standards. 

InnoStar has actively upheld its social responsibilities and engaged in various voluntary services organized by local communities. These initiatives, which include blood donations, visiting elderly residents in welfare homes, and participating in volunteer activities promoting civilized behaviors, have elevated the spiritual and cultural qualities of its employees. 

The company has also organized innovative events such as celebrations for festivals and employees’ birthdays and fitness walks, which have further heated up the harmonious atmosphere within the enterprise. 

InnoStar has achieved notable success in its operational endeavors, receiving certifications and recognitions from regulatory bodies such as the National Medical Products Administration for Good Laboratory Practice (GLP), the US Food and Drug Administration for GLP inspections, the GLP certification from the government of the Netherlands (an OECD member country), AAALAC accreditation and CAP certification from the College of American Pathologists. 

The company's consistent commitment to high-quality employee expertise, excellent operational capabilities and a positive social image has earned it the title of Shanghai Model Unit six consecutive times since 2009.

In 2022, the company further distinguished itself by receiving the Shanghai May Day Labor Certificate, solidifying its role as a role model in various aspects.